Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
NRx Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q2 2025 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q3 2025 | 1 | $0.04 | $0.04 | $0.04 |
| Q4 2025 | 1 | $0.07 | $0.07 | $0.07 |
| Q1 2026 | 1 | $0.40 | $0.40 | $0.40 |
| Q2 2026 | 1 | $0.56 | $0.56 | $0.56 |
| Q3 2026 | 1 | $0.61 | $0.61 | $0.61 |
| Q4 2026 | 1 | $0.75 | $0.75 | $0.75 |
| Q1 2027 | 1 | $2.55 | $2.55 | $2.55 |
| Q2 2027 | 1 | $2.66 | $2.66 | $2.66 |
| Q3 2027 | 1 | $2.66 | $2.66 | $2.66 |
| Q4 2027 | 1 | $2.76 | $2.76 | $2.76 |
| Q1 2028 | 1 | $5.27 | $5.27 | $5.27 |
| Q2 2028 | 1 | $5.48 | $5.48 | $5.48 |
| Q3 2028 | 1 | $5.47 | $5.47 | $5.47 |
| Q4 2028 | 1 | $5.69 | $5.69 | $5.69 |
NRx Pharmaceuticals, Inc. Earnings Date And Information
NRx Pharmaceuticals, Inc. last posted its earnings results on Thursday, May 15th, 2025. The company reported $-0.5241 earnings per share for the quarter, missing analysts' consensus estimates of $-0.28333 by $0.24077. The company had revenue of 0 for the quarter and had revenue of 0 for the year. NRx Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-2.39 diluted earnings per share) and currently has a price-to-earnings ratio of -1.4. NRx Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 17th, 2025 based on prior year's report dates.
NRx Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/18/2025 | Q2 2025 | N/A | -$0.98 | N/A | $3.50 M | $0 |
| 05/15/2025 | Q1 2025 | -$0.28 | -$0.34 | -0.06 | N/A | $0 |
| 03/14/2025 | Q4 2024 | N/A | -$0.86 | N/A | N/A | $4.00 K |
| 11/14/2024 | Q3 2024 | N/A | -$0.15 | N/A | N/A | $0 |
| 08/14/2024 | Q2 2024 | N/A | -$0.75 | N/A | N/A | $0 |
| 05/14/2024 | Q1 2024 | N/A | -$0.74 | N/A | N/A | $0 |
| 03/29/2024 | Q4 2023 | N/A | -$0.05 | N/A | N/A | $8.00 K |
| 09/29/2023 | Q3 2023 | N/A | -$0.74 | N/A | N/A | $0 |
| 08/14/2023 | Q2 2023 | N/A | -$0.12 | N/A | N/A | $0 |
| 05/15/2023 | Q1 2023 | N/A | -$0.19 | N/A | N/A | $0 |
| 03/31/2023 | Q4 2022 | N/A | -$0.09 | N/A | N/A | $0 |
| 11/14/2022 | Q3 2022 | N/A | -$0.14 | N/A | N/A | $0 |
| 08/15/2022 | Q2 2022 | N/A | -$0.07 | N/A | N/A | $0 |
| 05/16/2022 | Q1 2022 | N/A | -$0.18 | N/A | N/A | $0 |
| 03/31/2022 | Q4 2021 | N/A | -$0.60 | N/A | N/A | $0 |
| 11/15/2021 | Q3 2021 | N/A | -$0.38 | N/A | N/A | $0 |
| 08/16/2021 | Q2 2021 | N/A | -$61.30 | N/A | N/A | $0 |
| 05/20/2021 | Q1 2021 | N/A | -$0.71 | N/A | N/A | $0 |
| 04/01/2021 | Q4 2020 | N/A | -$16.73 | N/A | N/A | $0 |
| 11/16/2020 | Q3 2020 | N/A | -$0.14 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NRx Pharmaceuticals, Inc. Earnings: FAQ's
NRx Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 17th, 2025 based offlast year's report dates.
The conference call for NRx Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for NRx Pharmaceuticals, Inc.'s latest earnings report can be read online.
NRx Pharmaceuticals, Inc. (:NRXPW) has a recorded net income of $-25,126,000.NRx Pharmaceuticals, Inc. has generated $-2.39 earnings per share over the last four quarters.
NRx Pharmaceuticals, Inc. (:NRXPW) has a price-to-earnings ratio of -1.4 and price/earnings-to-growth ratio is 0.13.